indications for glp 1 agonists The science on GLP-1 receptor has outpaced the public narrative. While headlines chase the latest prescription numbers, evidence-based practice demands we hold the line: obesity is a chronic, relapsing condition; not Beyond Blood Sugar: A Scoping

Los estudios de microarray han identificado cambios en la expresin de genes implicados en regulacin del ciclo celular, apoptosis y respuesta al estrs tras el tratamiento con Epithalon

Pharmacokinetics and pharmacodynamics of sitagliptin, an inhibitor of dipeptidyl peptidase IV, in healthy subjects: results from two randomized, double-blind, placebo-controlled studies with single oral doses

Jaaro-Peled H, Ayhan Y, Pletnikov MV, Sawa A

Extrahepatic toxicity of acetaminophen: critical evaluation of the evidence and proposed mechanisms

Can the gut-brain axis provide insight into psilocybins therapeutic value in reducing stress

At the same time, a new ecosystem of weight management clinics has emerged, many of which specialize in pharmacologic obesity treatment and operate with a different clinical emphasis